bioRxiv Science⌕ Search

Biology subjects

Toulopoulou, T.

Publications and source records attributed to Toulopoulou, T..

2 recordsLinked to original sources

Causal Discovery Analysis Reveals Insights into Psychosis Proneness, Brain Function, and Environmental Factors among Young Individuals

BackgroundExperiencing symptoms of psychosis, such as delusions and hallucinations, are observed in general, nonclinical populations. These experiences are sometimes described as psychosis proneness (PP) and potentially part of the psychosis continuum. The directional relationships among various factors contributing to psychosis proneness and its interactions, encompassing both environmental and neural mechanisms, lack comprehensive description. We aimed to identify targets to prevent psychosis proneness and its interactions by characterizing pathways using causal discovery analysis (CDA). MethodsParticipants were 194 healthy adolescent and young adult twin and sibling pairs aged between 14-24 years from Turkiye. They completed comprehensive assessments evaluating sociodemographic status, environmental risk, general intelligence, self-schema, PP, and working memory (WM) performance during fMRI (37 variables). CDA was applied, a novel machine learning algorithm, to understand the causal relationships of PP. ResultsThe analysis identified negative self-schema as having the largest causal effect among all assessments in PP [Effect size (ES)= 0.55]. Secondly, social cohesion and trust (SC&T) had a protective causal effect on PP [ES= -0.18]. Lastly, PP was identified as a direct cause of greater activation in DLPFC (BA9a-BA46v) during manipulation in the WM (ES= 0.14). ConclusionsCDA provides directionality of the 37 variables which were not presented earlier. The findings highlight the significance of negative self-schema and SC&T in the general population with PP, emphasizing the potential for preventive interventions targeting these factors. These findings also suggest a role for DLPFC as a potential target in this regard. To our knowledge, this is the first study using data-driven analysis to model causal mechanisms in PP in the general population.

neuroscience↗

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia.

ObjectivePsychosis - a complex and heterogeneous neuropsychiatric condition characterized by hallucinations and delusions - is a common feature of schizophrenia. There is evidence for altered DNA methylation (DNAm) associated with schizophrenia in both brain and peripheral tissues. We aimed to undertake a systematic analysis of variable DNAm associated with psychosis, schizophrenia, and treatment-resistant schizophrenia, also exploring measures of biological ageing, smoking, and blood cell composition derived from DNAm data to identify molecular biomarkers of disease. MethodsWe quantified DNAm across the genome in blood samples from 4,483 participants from seven case-control cohorts including patients with schizophrenia or first-episode psychosis. Measures of biological age, cellular composition and smoking status were derived from DNAm data using established algorithms. DNAm and derived measures were analyzed within each cohort and the results combined by meta-analysis. ResultsPsychosis cases were characterized by significant differences in measures of blood cell proportions and elevated smoking exposure derived from the DNAm data, with the largest differences seen in treatment-resistant schizophrenia patients. DNAm at 95 CpG sites was significantly different between psychosis cases and controls, with 1,048 differentially methylated positions (DMPs) identified between schizophrenia cases and controls. Schizophrenia-associated DMPs colocalize to regions identified in genetic association studies, with genes annotated to these sites enriched for pathways relevant to disease. Finally, a number of the schizophrenia associated differences were only present in the treatment-resistant schizophrenia subgroup. ConclusionsWe show that DNAm data can be leveraged to derive measures of blood cell counts and smoking that are strongly associated with psychosis. Our DNAm meta-analysis identified multiple DMPs associated with both psychosis and a more refined diagnosis of schizophrenia, with evidence for differential methylation associated with treatment-resistant schizophrenia that potentially reflects exposure to clozapine.

genomics↗